IMVAQ Therapeutics

About:

Imvaq Therapeutics is an innovative cancer immunotherapy company.

Top Investors: Hanne Capital

Description:

Imvaq is a biotechnology firm developing novel immuno-oncologics to treat metastatic cancer. It focuses on developing therapeutic products that work in tandem with a patient's immune system to eradicate cancer locally and globally.

Total Funding Amount:

$20M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sammamish, Washington, United States

Founded Date:

2018-01-01

Founders:

Jedd Wolchok, John Choi, Liang Deng, Stewart Schuman, Wei Yan

Number of Employees:

1-10

Last Funding Date:

2020-08-31

IPO Status:

Private

Industries: